Table 4.
Dairy variable |
Total dairy (kcal/d) |
Dairy-milk (kcal/d) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Cancer receptor(s) | n(cases) | HRb | 95% CI | p1d | p2d | HRb | 95% CI | p1d | p2d |
ER+ | 737 | 1.25 | 1.06–1.48 | 0.008 | 0.79 | 1.36 | 1.08–1.71 | 0.008 | 0.55 |
ER− | 172 | 1.31 | 0.98–1.76 | 0.07 | – | 1.52 | 1.03–2.24 | 0.04 | – |
PR+ | 615 | 1.30 | 1.08–1.56 | 0.006 | 0.43 | 1.45 | 1.13–1.86 | 0.003 | 0.36 |
PR− | 282 | 1.17 | 0.94–1.56 | 0.16 | – | 1.22 | 0.89–1.66 | 0.22 | – |
ER+/PR− | 116 | 1.06 | 0.77–1.47 | 0.71 | 0.56 | 0.98 | 0.62–1.53 | 0.92 | 0.42 |
ER+/PR+ | 608 | 1.29 | 1.07–1.56 | 0.007 | 0.88 | 1.43 | 1.11–1.83 | 0.005 | 0.94 |
ER−/PR− | 165 | 1.27 | 0.94–1.71 | 0.11 | 0.42 | 1.43 | 0.97–2.11 | 0.074 | 0.18 |
ER−/PR+ | 7 | c | c | c | - | c | c | c | - |
Same covariates as those listed as footnotes to Table 1 for model 2.
Comparing medians of extreme quintiles of dairy intake.
Insufficient cases.
p1 relates to the test of whether the dairy variable has a CI that includes the null for that named cancer subtype; p2 relates to a test of whether the slope of association between the dairy variable differs between the named cancer subtype and that in the row below it. An exception is that the second to last line tests ER− /PR− vs ER+/PR−. Chi square joint Wald tests of no difference between the ER/PR combinations gave p = 0.80 (dairy kcals) and p = 0.58 (dairy milks).